Your browser doesn't support javascript.
loading
Single-domain intrabodies against hepatitis C virus core inhibit viral propagation and core-induced NFκB activation.
Suzuki, Ryosuke; Saito, Kenji; Matsuda, Mami; Sato, Mitsuru; Kanegae, Yumi; Shi, Guoli; Watashi, Koichi; Aizaki, Hideki; Chiba, Joe; Saito, Izumu; Wakita, Takaji; Suzuki, Tetsuro.
Afiliación
  • Suzuki R; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Saito K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Matsuda M; Department of Biological Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Sato M; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kanegae Y; Animal Immune and Cell Biology Research Unit, National Institute of Agrobiological Sciences, Ibaraki, Japan.
  • Shi G; Laboratory of Molecular Genetics, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Watashi K; Department of Infectious Diseases, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Aizaki H; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Chiba J; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Saito I; Department of Biological Science and Technology, Tokyo University of Science, Chiba, Japan.
  • Wakita T; Laboratory of Molecular Genetics, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Suzuki T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
J Gen Virol ; 97(4): 887-892, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26861864
ABSTRACT
Hepatitis C virus (HCV) core plays a key role in viral particle formation and is involved in viral pathogenesis. Here, constructs for single-domain intrabodies consisting of variable regions derived from mouse mAbs against HCV core were established. Expressed single-domain intrabodies were shown to bind to HCV core, and inhibit the growth of cell culture-produced HCV derived from JFH-1 (genotype 2a) and a TH (genotype 1b)/JFH-1 chimera. Adenovirus vectors expressing intrabodies were also capable of reducing HCV propagation. Intrabody expression did not affect viral entry or genome replication of single-round infectious trans-complemented HCV particles. However, intrabody expression reduced intracellular and extracellular infectious titres in CD81-defective Huh7-25 cells transfected with the HCV genome, suggesting that these intrabodies impair HCV assembly. Furthermore, intrabody expression suppressed HCV core-induced NFκB promoter activity. These intrabodies may therefore serve as tools for elucidating the role of core in HCV pathogenesis.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas del Núcleo Viral / Hepacivirus / Hepatocitos / Anticuerpos de Dominio Único / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: J Gen Virol Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas del Núcleo Viral / Hepacivirus / Hepatocitos / Anticuerpos de Dominio Único / Anticuerpos Monoclonales / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: J Gen Virol Año: 2016 Tipo del documento: Article País de afiliación: Japón